maddison, i will try to stay positive, you started the prediction #$%$ all over again, so who are you to say things to me. as for NVS, it is really a mute point what the sales are, it is maybe a 2-3 million dollar increase from last quarter, in terms of a payment to incyte. Maybe you need to go back and look at my 2nd q predictions again. . What WILL be more important is how is the approval process coming in europe, so incyte can get their 60 million. Also any NEWS regarding the pancreatic trial. other than that i think it will be a ho-hum earnings call, as they really want to put 2q of 2012 behind them for good.